Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer
{{output}}
Purpose: Modified FOLFIRINOX (mFFX) therapy is widely used as first- or second-line treatment for advanced pancreatic cancer. However, adverse effects (AEs), such as cytopenia, often prevent the intended biweekly administration o... ...
